Eli Lilly Beats Cymbalta Withdrawal Risk Suit
Eli Lily Pharmaceutal Co. persuaded a Texas federal court Thursday to throw out a proposed class action by a woman claiming its antidepressant Cymbalta caused withdrawal symptoms that she said the...To view the full article, register now.
Already a subscriber? Click here to view full article